3 enrolling by invitation, 1 completed. 4 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Enrolling by invitation 3, Completed 1 |
Follow Varol TUNALI: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AIM-TEST: Microbiome-Targeted Nutrition for Functional Secondary Hypogonadism Fixed-Formula Microbiome-Targeted Oral Nutritional Supplement, Matched Oral Placebo - Hypogonadism, Male, Secondary Hypogonadism | Not applicable | Enrolling by invitation | Varol TUNALI | 112 | 2026-08-15 | 2026-09-29 |
| AIM-WEIGHT: AI-Guided Microbiome-Targeted Nutritional Intervention for Weight Loss AI-Guided Microbiome-Targeted Nutritional Supplement, Matching Placebo (B), Lifestyle counselling - Overweight (Without Type 2 Diabetes) With Weight-related Comorbidities, Overweight (BMI > 25) | Not applicable | Enrolling by invitation | Varol TUNALI | 80 | 2026-07-01 | 2026-09-29 |
| Microbiome-Focused Food Supplement for Evaporative Dry Eye Due to Meibomian Gland Dysfunction Dietary Supplement: Microbiome-targeted oral supplement, Placebo - Dry Eye, Evaporative Dry Eye Disease | Not applicable | Enrolling by invitation | Varol TUNALI | 130 | 2026-03-01 | 2026-11-10 |
| Effect of a Dietary Supplement on Gut Microbiota and Ocular Surface Outcomes in Dry Eye Disease Dietary Supplement Product - Dry Eye, Meibomian Gland Dysfunction (Disorder) | Not applicable | Completed | Varol TUNALI | 20 | 2025-10-01 | 2026-10-06 |
Dry Eye Syndromes (2) · Meibomian Gland Dysfunction (2) · Erectile Dysfunction (1) · Eunuchism (1) · Hypogonadism (1) · Obesity (1) · Overweight (1) · Weight Loss (1)
Turkey (Türkiye) (4)